Education
About Us
Working with TipRanks
Follow Us
TELA Bio (TELA)
NASDAQ:TELA
Total Valuation
TELA Bio has a market cap or net worth of $38.17M. The enterprise value is $111.41M.
Market Cap$38.17M
Enterprise Value$111.41M
Share Statistics
TELA Bio has 39,554,770 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,554,770
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
TELA Bio’s return on equity (ROE) is -1.33 and return on invested capital (ROIC) is -47.89%.
Return on Equity (ROE)-1.33
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-47.89%
Return on Capital Employed (ROCE)-0.48
Revenue Per Employee331.58K
Profits Per Employee-181.06K
Employee Count209
Asset Turnover0.80
Inventory Turnover1.78
Valuation Ratios
The current PE Ratio of TELA Bio is -2.28. TELA Bio’s PEG ratio is 0.07.
PE Ratio-2.28
PS Ratio0.00
PB Ratio3.03
Price to Fair Value3.03
Price to FCF-2.02
Price to Operating Cash Flow-2.07
PEG Ratio0.07
Income Statement
In the last 12 months, TELA Bio had revenue of 69.30M and earned -37.84M in profits. Earnings per share was -1.33.
Revenue69.30M
Gross Profit46.49M
Operating Income-34.12M
Pretax Income-37.98M
Net Income-37.84M
EBITDA-31.68M
Earnings Per Share (EPS)-1.33
Cash Flow
In the last 12 months, operating cash flow was -41.59M and capital expenditures -989.00K, giving a free cash flow of -42.58M billion.
Operating Cash Flow-41.59M
Free Cash Flow-42.58M
Free Cash Flow per Share-1.08
Dividends & Yields
TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-81.28%
50-Day Moving Average1.45
200-Day Moving Average2.55
Relative Strength Index (RSI)46.98
Average Volume (3m)280.36K
Important Dates
TELA Bio upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
TELA Bio as a current ratio of 5.01, with Debt / Equity ratio of 146.42%
Current Ratio5.01
Quick Ratio4.19
Debt to Market Cap0.48
Net Debt to EBITDA0.35
Interest Coverage Ratio-6.45
Taxes
In the past 12 months, TELA Bio has paid -144.00K in taxes.
Income Tax-144.00K
Effective Tax Rate<0.01
Enterprise Valuation
TELA Bio EV to EBITDA ratio is -2.37, with an EV/FCF ratio of -1.76.
EV to Sales1.08
EV to EBITDA-2.37
EV to Free Cash Flow-1.76
EV to Operating Cash Flow-1.81
Balance Sheet
TELA Bio has $52.67M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$11.00M billion.
Cash & Marketable Securities$52.67M
Total Debt$0.00
Net Cash-$11.00M
Net Cash Per Share-$0.28
Tangible Book Value Per Share$0.94
Margins
Gross margin is 67.08%, with operating margin of -49.23%, and net profit margin of -54.60%.
Gross Margin67.08%
Operating Margin-49.23%
Pretax Margin-54.81%
Net Profit Margin-54.60%
EBITDA Margin-45.72%
EBIT Margin-47.18%
Analyst Forecast
The average price target for TELA Bio is $5.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.50
Price Target Upside409.26% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast18.56%
EPS Growth Forecast32.65%